Novel ways to monitor the immune system in lymphoma clinical trials
Mayo Clinic hematologist, J.C. Villasboas, M.D., discusses a new way to measure and monitor a lymphoma patient's immune system during treatment. What used to take five or more blood draws, can now be done in one using what is called mass cytometry.
The benefit for the patient is less blood draws for the same, and sometimes more, information. For researchers, data can now be collected and different immune cells can be mapped in larger numbers and more accurately.
Learn more about the process and how it may benefit patients and researchers in the following video,
Are you living with a lymphoma, blood cancer or disorder? Meet others like you right here on Connect:
More from Dr. Villasboas:
- Immunotherapy to fight cancer: What is it and how does it work?
- Immunotherapy to fight cancer: Dual-immunomodulation
- In the Halls of Hematology: Meet Dr. Villasboas
Click here to learn more about clinical trials at Mayo Clinic.
Interested in more newsfeed posts like this? Go to the Hematology blog.
Hello Dr. Villasboas,
Are there active clinical trials currently in the southern parts of the U.S. with T-PLL patient's. If so, where are they and are new treatments being tested for my rare form of leukemia? Any answers will be greatly appreciated.
Hi @sharonmb, you can contact Mayo Clinic Clinical Research to inquire about the availability of clinical trials available to you.
Phone: 855-776-0015 (toll-free)